Skip to main content

Table 3 Proteins identified by mass spectrometry

From: A proteomic analysis of serum-derived exosomes in rheumatoid arthritis

Spot ID

Observed

Fold difference

Protein

Theoretical

Masscot Score

Coverage (%)

Confirmed Sequences (Masscot ion score)

Search log

MW

pI

wRA

OA

HL

MW

pI

aRA

iRA

208

90

5.3

1.4*

1.0

1.0

Pro-neuregulin-3, membrane-bound isoform

78

7.8

61

12

388QAKQIQEQLK397(19)

38,220

NRG3_HUMAN

236

87

5.1

1.1

1.3*

1.0

Cathepsin F

53

8.5

26

3

103TLLCSFQVLDELGRHVLLR121(26)

38,210

CATF_HUMAN

peptide summary

325

65

5.1

0.9

0.7*

1.0

Ig alpha-2 chain C region

37

5.7

132

10

251WLQGSQELPR260(53)

38,207

IGHA2_HUMAN

270QEPSQGTTTFAVTSILR286(70)

370

53

5.1

1.3*

0.9

0.9

1.0

Alpha-1-antitrypsin

47

5.4

170

33

50ITPNLAEFAFSLYR63(79)

38,190

A1AT_HUMAN

216GKWERPFEVK225(10)

494

40

7.0

0.7*

0.9

0.9

1.0

Keratin, type II cytoskeletal 1

66

8.2

62

9

212WELLQQVDTSTR223(14)

38,206

K2C1_HUMAN

224THNLEPYFESFINNLR239(41)

564

24

5.2

6.3*

1.2

1.1

1.0

Toll-like receptor 3

104

6.7

68

19

532LEILDLQHNNLAR544(7)

38,215

TLR3_HUMAN

  1. MW molecular weight, wRA whole RA, aRA active RA, iRA inactive RA, OA osteoarthritis, HL healthy donor
  2. Fold differences are shown with the intensity of the protein spots in HLs defined as 1.0. Asterisks indicate that the spot intensity is significantly different (p < 0.05) from that in HLs